Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-07-02 4:01 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | Deep Track Capital LP | 3,904,785 5.85% | 3,904,785![]() (New Position) | View |
2024-07-01 9:28 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 31,459,267 47.1% | 18,268,418![]() (+138.49%) | View |
2024-06-06 4:16 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,190,849 44.3% | 557![]() (+0.00%) | View |
2024-05-17 4:18 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,190,292 45.3% | 556![]() (+0.00%) | View |
2024-05-17 4:01 pm Unchanged | 13D | Eliem Therapeutics Inc. ELYM | AI ETI LLC | 5,009,400 17.2% | 0 (Unchanged) | View |
2024-05-07 6:01 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | Affinity Asset Advisors LLC | 1,670,000 6.02% | 1,670,000![]() (New Position) | View |
2024-04-12 6:52 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,189,736 47.5% | 10,555![]() (+0.08%) | View |
2024-03-18 4:46 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,179,181 47.5% | 2,778![]() (+0.02%) | View |
2024-02-07 11:53 am Purchase | 13G | Eliem Therapeutics Inc. ELYM | BML Investment Partners L.P. | 2,350,682 8.5% | 453,068![]() (+23.88%) | View |
2023-11-17 4:30 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,176,403 47.7% | 13,332![]() (+0.10%) | View |
2023-11-13 5:13 pm Unchanged | 13D | Eliem Therapeutics Inc. ELYM | AI ETI LLC | 5,009,400 18.5% | 0 (Unchanged) | View |
2023-04-10 5:01 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | RA CAPITAL MANAGEMENT L.P. | 13,163,071 48.8% | 11,112![]() (+0.08%) | View |
2023-03-08 4:00 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | Intermediate Capital Group plc | 2,002,563 7.5% | 2,002,563![]() (New Position) | View |
2023-02-14 2:22 pm Sale | 13G | Eliem Therapeutics Inc. ELYM | SAMLYN CAPITAL LLC | 0 0% | -2,128,202![]() (Position Closed) | View |
2023-02-08 4:35 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | BML Investment Partners L.P. | 1,897,614 7.1% | 158,236![]() (+9.10%) | View |
2022-09-22 5:02 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | ICG Life Sciences SCSp | 2,002,563 7.5% | 2,002,563![]() (New Position) | View |
2022-05-04 11:25 am Purchase | 13G | Eliem Therapeutics Inc. ELYM | BML Investment Partners L.P. | 1,739,378 6.5% | 1,739,378![]() (New Position) | View |
2022-04-04 5:12 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | SAMLYN CAPITAL LLC | 2,128,202 8% | 424,656![]() (+24.93%) | View |
2022-02-14 1:42 pm Purchase | 13G | Eliem Therapeutics Inc. ELYM | SAMLYN CAPITAL LLC | 1,703,546 6.4% | 1,703,546![]() (New Position) | View |
2021-08-23 3:52 pm Purchase | 13D | Eliem Therapeutics Inc. ELYM | AI ETI LLC | 5,009,400 19.8% | 5,009,400![]() (New Position) | View |